{"log_id": 4282149846812692800, "direction": 0, "words_result_num": 53, "words_result": [{"probability": {"variance": 0.026196, "average": 0.899245, "min": 0.390258}, "location": {"width": 1129, "top": 208, "height": 50, "left": 260}, "words": "汁托拉为质子泵排制剂,通过与胃壁细胞的H-KAlP酶系统的两个位点夫价结合抑制"}, {"probability": {"variance": 0.033798, "average": 0.906546, "min": 0.376093}, "location": {"width": 1179, "top": 246, "height": 50, "left": 208}, "words": "胃产生的最后步骤该作月呈剂量依赖性并基础刺激状态下的胃酸分泌均受抑。本品"}, {"probability": {"variance": 0.006257, "average": 0.962114, "min": 0.656336}, "location": {"width": 795, "top": 290, "height": 38, "left": 210}, "words": "与H-KATP的的结合可导致其抗导酸分泌作用持线24小时以L"}, {"probability": {"variance": 0.008412, "average": 0.927242, "min": 0.77057}, "location": {"width": 116, "top": 336, "height": 32, "left": 208}, "words": "毒理研究"}, {"probability": {"variance": 0.043927, "average": 0.876056, "min": 0.513085}, "location": {"width": 121, "top": 374, "height": 34, "left": 205}, "words": "遗传毒性"}, {"probability": {"variance": 0.020317, "average": 0.927375, "min": 0.379973}, "location": {"width": 1129, "top": 397, "height": 52, "left": 262}, "words": "泮托拉唑的人淋已细胞染色体变试验、中玉仓鼠卵果细胞/GPRT正向突变试验及二次小"}, {"probability": {"variance": 0.013477, "average": 0.954635, "min": 0.445301}, "location": {"width": 1195, "top": 436, "height": 50, "left": 203}, "words": "鼠微核试验中的一次结均为阳性,而大鼠脏DNA共价结合试验结果雌以判断.Ames试"}, {"probability": {"variance": 0.018225, "average": 0.922854, "min": 0.362586}, "location": {"width": 1188, "top": 473, "height": 52, "left": 205}, "words": "验、大肝细胞程序外DNA台成试验(UDS、AS52GPT哺乳动物细胞正向基因突变试验、小"}, {"probability": {"variance": 0.022754, "average": 0.90447, "min": 0.398937}, "location": {"width": 1188, "top": 512, "height": 52, "left": 205}, "words": "鼠淋巴瘤L5178Y细胸腺嘧激酶突变试验及体内大骨髓纤胞染名体畸变试验结果均为阴"}, {"probability": {"variance": 0, "average": 0.972413, "min": 0.972413}, "location": {"width": 34, "top": 567, "height": 32, "left": 205}, "words": "性"}, {"probability": {"variance": 5e-06, "average": 0.996096, "min": 0.992079}, "location": {"width": 118, "top": 603, "height": 32, "left": 208}, "words": "生殖毒性"}, {"probability": {"variance": 0.0139, "average": 0.931232, "min": 0.436598}, "location": {"width": 1134, "top": 626, "height": 54, "left": 262}, "words": "雄太鼠经口给予泮托拉唑50mg/Kgld(按体衣面积折算,为临床推荐口服剂量的98"}, {"probability": {"variance": 0.023569, "average": 0.908387, "min": 0.423918}, "location": {"width": 1182, "top": 669, "height": 48, "left": 210}, "words": "倍),雌性大鼠经口给予泮托拉唑450mg7Kg/(按体表面积折算,为临末荐口服剂的88"}, {"probability": {"variance": 0.023461, "average": 0.935507, "min": 0.392617}, "location": {"width": 516, "top": 713, "height": 38, "left": 210}, "words": "倍)时,育力及生殖行为末明显异常"}, {"probability": {"variance": 0.021609, "average": 0.922139, "min": 0.395207}, "location": {"width": 1129, "top": 745, "height": 48, "left": 265}, "words": "大鼠静脉给泮托拉唑20 )me, K p,d(按体表面积折算:为临床推荐口报剂量的4),免"}, {"probability": {"variance": 0.030218, "average": 0.870755, "min": 0.442553}, "location": {"width": 1191, "top": 781, "height": 50, "left": 208}, "words": "静脉给于泮托拉唑15m2/kgd(按体衣面积折算:为木推荐口服剂量的6倍),对生育力和胎"}, {"probability": {"variance": 0.027936, "average": 0.917537, "min": 0.400351}, "location": {"width": 802, "top": 825, "height": 41, "left": 208}, "words": "均未见明显损害。托拉唑及其代谢产物可从家免乳中分泌"}, {"probability": {"variance": 6.9e-05, "average": 0.990852, "min": 0.97943}, "location": {"width": 91, "top": 871, "height": 32, "left": 208}, "words": "致癌性"}, {"probability": {"variance": 0.030656, "average": 0.848858, "min": 0.358419}, "location": {"width": 1131, "top": 893, "height": 52, "left": 269}, "words": "SD大鼠连续24个月经口绘子泮托拉0.5~200mgKg/L胃底出现剂量浓赖的肠者铭样"}, {"probability": {"variance": 0.019678, "average": 0.913525, "min": 0.407284}, "location": {"width": 1191, "top": 932, "height": 52, "left": 208}, "words": "细胞增生及良性和恶位的神经内分泌胞瘤,当剂量为50和200 Img/'kgd〔按体表面积算为"}, {"probability": {"variance": 0.018645, "average": 0.937522, "min": 0.410981}, "location": {"width": 1225, "top": 973, "height": 45, "left": 208}, "words": "临床推荐口剂量的10和40倍)时,前胃山现性鳞状细胞乳头状疼和恶性鳞状细泡症洋"}, {"probability": {"variance": 0.024153, "average": 0.907506, "min": 0.466804}, "location": {"width": 1191, "top": 1012, "height": 50, "left": 208}, "words": "托拉唑还导致极少数大电出现胃肠道肿瘤,包括5 mg/kg'd剂量时偶出现十三指肠腺瘤;以"}, {"probability": {"variance": 0.036471, "average": 0.863459, "min": 0.362383}, "location": {"width": 1188, "top": 1051, "height": 50, "left": 210}, "words": "及20cmg/Kg/剂时底出现良性息肉腺深泮托拉药剂量0.5200mgKg日"}, {"probability": {"variance": 0.038711, "average": 0.846834, "min": 0.36642}, "location": {"width": 1218, "top": 1085, "height": 54, "left": 208}, "words": "剂量依赖性地坐现肝细胞腺痘和肝癌:2C0 Jmg/ Kg/d剂量还可使大锅甲状腺囊泡细胞和襄址"}, {"probability": {"variance": 0.027523, "average": 0.906148, "min": 0.352085}, "location": {"width": 1051, "top": 1129, "height": 43, "left": 210}, "words": "胞癌的发生率增加。5大鼠6个月和12个月的毒性研究中也见细胞瘤和肝症"}, {"probability": {"variance": 0.035258, "average": 0.861039, "min": 0.384047}, "location": {"width": 1129, "top": 1163, "height": 52, "left": 272}, "words": " Fischer3<4大陆连续24个月经11予件托拉550 mg/Kgrd(按体表面积算为床推"}, {"probability": {"variance": 0.024226, "average": 0.913008, "min": 0.410745}, "location": {"width": 1184, "top": 1200, "height": 54, "left": 212}, "words": "荐口服剂量的1~10倍),胃底剂量依性出现肠嗜铭栏细琼增生及良性和恶的神经内分泌细"}, {"probability": {"variance": 0.02024, "average": 0.925473, "min": 0.473115}, "location": {"width": 916, "top": 1243, "height": 50, "left": 210}, "words": "胞瘤。但该试验的剂量选择不足以支持对泮托泣潜在致癌性的充分评价"}, {"probability": {"variance": 0.027119, "average": 0.89261, "min": 0.384538}, "location": {"width": 1134, "top": 1280, "height": 50, "left": 269}, "words": "B6C3F1小连续24个月经口服给予泮拉唑5150 mg/Kgd(按体表面积折算,为临床推"}, {"probability": {"variance": 0.025659, "average": 0.901317, "min": 0.368585}, "location": {"width": 1188, "top": 1319, "height": 52, "left": 212}, "words": "荐口服剂量的0.5~15倍),同样出现胃底肠嗜铬样细胞堵生:雌鼠在150mK星时,肝"}, {"probability": {"variance": 0.043486, "average": 0.864435, "min": 0.433048}, "location": {"width": 379, "top": 1367, "height": 36, "left": 212}, "words": "细瘤和肝症的发生率升高"}, {"probability": {"variance": 0.016557, "average": 0.93839, "min": 0.527492}, "location": {"width": 1111, "top": 1392, "height": 54, "left": 272}, "words": "⊥述齿类动物的致癌性研究提示本品具有一定的致症性,此结果与临床的排文"}, {"probability": {"variance": 0.000275, "average": 0.983329, "min": 0.964382}, "location": {"width": 123, "top": 1447, "height": 32, "left": 212}, "words": "尚不清楚"}, {"probability": {"variance": 0, "average": 0.754971, "min": 0.754971}, "location": {"width": 29, "top": 1440, "height": 32, "left": 1099}, "words": "心"}, {"probability": {"variance": 0.004254, "average": 0.96996, "min": 0.824125}, "location": {"width": 180, "top": 1483, "height": 34, "left": 221}, "words": "【药代动刀学"}, {"probability": {"variance": 0.031556, "average": 0.894582, "min": 0.355317}, "location": {"width": 1106, "top": 1508, "height": 50, "left": 269}, "words": "泮托泣唑血药浓度(Cmx)和血药浓度-时间曲线下面积(AUC)与10mg至80mg厨"}, {"probability": {"variance": 0.021733, "average": 0.938013, "min": 0.350914}, "location": {"width": 1163, "top": 1545, "height": 54, "left": 214}, "words": "注射给约剂量增加成比例。泮托拉唑不菩积每日多次给药不改变其代动力学性质"}, {"probability": {"variance": 0.029119, "average": 0.925477, "min": 0.366387}, "location": {"width": 1168, "top": 1582, "height": 57, "left": 214}, "words": "注射泮托拉唑钢后,其血药浓度快速下降,消除半衰期约为一小时,在2C门丙谢"}, {"probability": {"variance": 0.007868, "average": 0.961638, "min": 0.54268}, "location": {"width": 944, "top": 1627, "height": 48, "left": 214}, "words": "型且町功能正常的人群中,十五分钟内恒速静脉注射泮托拉钠40mg"}, {"probability": {"variance": 0, "average": 0.994867, "min": 0.994867}, "location": {"width": 91, "top": 1627, "height": 34, "left": 1289}, "words": "浓"}, {"probability": {"variance": 0.028828, "average": 0.893032, "min": 0.387601}, "location": {"width": 1140, "top": 1664, "height": 50, "left": 242}, "words": "Cmx)为5.521.42gml,血药浓度-时间的总出线下面积为5.4±1.5 u g hmi,总清除率为"}, {"probability": {"variance": 0.021307, "average": 0.904887, "min": 0.518983}, "location": {"width": 160, "top": 1717, "height": 27, "left": 219}, "words": "7.6~14.0L1"}, {"probability": {"variance": 0, "average": 0.999594, "min": 0.999594}, "location": {"width": 59, "top": 1753, "height": 32, "left": 219}, "words": "分"}, {"probability": {"variance": 0.022202, "average": 0.907765, "min": 0.418686}, "location": {"width": 1147, "top": 1774, "height": 52, "left": 274}, "words": "泮托拉唑的表观分布容积约为11.023.6,主要分布在细外液。泮托拉唑的血清蛋白"}, {"probability": {"variance": 0.000136, "average": 0.992228, "min": 0.956342}, "location": {"width": 384, "top": 1826, "height": 34, "left": 217}, "words": "结合率约98%,主要为白蛋白"}, {"probability": {"variance": 0.000279, "average": 0.982521, "min": 0.965814}, "location": {"width": 61, "top": 1867, "height": 32, "left": 221}, "words": "代谢"}, {"probability": {"variance": 0.00398, "average": 0.963746, "min": 0.744592}, "location": {"width": 1106, "top": 1888, "height": 54, "left": 274}, "words": "泮托拉唑广泛在肝脏通过细胞色素P450(CYP)系统代,药物代谢与给药途径静"}, {"probability": {"variance": 0.011616, "average": 0.939083, "min": 0.609117}, "location": {"width": 1168, "top": 1929, "height": 52, "left": 217}, "words": "给药或口服)无关,主要代谢途径是由CYP2C19基因去甲基化后硫酸化,其他代谢诠径包括"}, {"probability": {"variance": 0.019051, "average": 0.928628, "min": 0.464779}, "location": {"width": 1166, "top": 1973, "height": 38, "left": 219}, "words": "通过CYP3A4氧化,没有证据表明泮拉唑代谢物有显著的药理活:CYP2C19国一些业"}, {"probability": {"variance": 0.02745, "average": 0.911134, "min": 0.374499}, "location": {"width": 1161, "top": 2002, "height": 52, "left": 219}, "words": "群的缺失而具逵传多态性(例如,3%的白种人和丰美国人及17%-235的亚洲人),"}, {"probability": {"variance": 0.024395, "average": 0.923901, "min": 0.416698}, "location": {"width": 1166, "top": 2041, "height": 52, "left": 219}, "words": "然亚群缓慢代谢泮打拉唑的消除半衰期值为3.5到10.0小时,但他们每天给药一次,很"}, {"probability": {"variance": 0.003361, "average": 0.962172, "min": 0.825498}, "location": {"width": 150, "top": 2096, "height": 27, "left": 221}, "words": "少(<23%)"}, {"probability": {"variance": 0.001963, "average": 0.950096, "min": 0.905789}, "location": {"width": 64, "top": 2130, "height": 34, "left": 219}, "words": "排泄"}], "language": 3}